Biotechnology Assets (XMAD:BST) Dividends per Share: €0.00 (TTM As of Dec. 2025)

What is Biotechnology Assets Dividends per Share?

Biotechnology Assets XMAD:BST -1.75% 22 Dividends per Share is €0.00 as of Dec. 2025. GuruFocus rates XMAD:BST with a GF Score™ of 22/100 and a GF Value™ of €0.30 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Biotechnology Assets's dividends per share for the six months ended in Dec. 2025 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00. Its Dividend Payout Ratio for the six months ended in Dec. 2025 was 0.00. As of today, Biotechnology Assets's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Biotechnology Assets (XMAD:BST) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Biotechnology Assets's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2025 )	/	EPS without NRI (Q: Dec. 2025 )
	=	0	/	-0.008
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotechnology Assets Dividends per Share Related Terms

Biotechnology Assets Dividends per Share Historical Data

* Premium members only.

The historical data trend for Biotechnology Assets's Dividends per Share can be seen below:

Biotechnology Assets Dividends per Share Chart

Biotechnology Assets Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Dividends per Share

Get a 7-Day Free Trial

0.00

Biotechnology Assets Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Dividends per Share	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

XMAD:BST vs VRTX, REGN, ALNY: Dividends per Share Comparison

For the Biotechnology subindustry, Biotechnology Assets's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotechnology Assets Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotechnology Assets's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Biotechnology Assets's Dividend Yield % falls into.

Save Embed

22GF Score

Biotechnology Assets SA XMAD:BST

Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Biotechnology Assets Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →

What does a Dividends per Share of €0.00 mean?

Biotechnology Assets (XMAD:BST) has a Dividends per Share of €0.00 as of Dec. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on Biotechnology Assets and its competitors.

Is Biotechnology Assets' Dividends per Share too high?

Biotechnology Assets' current Dividends per Share is €0.00. Overall, Biotechnology Assets has a GF Score™ of 22/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Biotechnology Assets' Dividends per Share compare to VRTX and REGN?

Biotechnology Assets' Dividends per Share of €0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Dividends per Share for a Biotechnology company?

A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Dividends per Share mean?

A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Biotechnology Assets and its competitors. Biotechnology Assets's current Dividends per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Biotechnology Assets stock overvalued right now?

Based on GuruFocus' analysis, Biotechnology Assets (XMAD:BST) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.30, compared to a current price of €0.23 — trading 25% below its estimated fair value. The current Dividends per Share is €0.00. Biotechnology Assets' overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Dividends per Share calculated?

Dividends per Share is calculated from a company's financial statements. For Biotechnology Assets (XMAD:BST), the current Dividends per Share is €0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biotechnology Assets (XMAD:BST) Overvalued in 2026?

Based on GuruFocus' analysis, Biotechnology Assets stock appears to be undervalued. The current stock price of €0.23 is trading 25% below its estimated GF Value™ of €0.30. GuruFocus considers Biotechnology Assets to be Modestly Undervalued.

Key valuation signals for XMAD:BST:

Dividends per Share: €0.00
GF Value™: €0.30 vs. price of €0.23 (25% below fair value)
GF Score™: 22/100 with 3 warning signs

No single metric tells the full story. See the XMAD:BST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biotechnology Assets Business Description

Industry Healthcare Biotechnology

Comparable Companies VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA XKRX:068270 RPRX ROIV BNTX INCY INSM HKSE:02269 ASND HKSE:01801 OCSE:GMAB

Address Avenida del Desarrollo Tecnologico, No. 11, Scientific and Technological Park, Jerez de la Frontera, ESP, 11591

Website https://www.biatgroup.com

Biotechnology Assets SA is a clinical-stage biopharmaceutical company developing and producing biological products for the pharmaceutical and veterinarian sectors. It specializes in the prevention and treatment of niche diseases, such as orphan disease, antigens for new-generation vaccines, feed additives, and probiotics. Adl Bionatur offers a portfolio of non-therapeutic and therapeutic products to tier 1 and tier 2 animal health companies. The company's pipeline products include BNT006, BNT007, BNT010, and others.

22GF Score

Get the complete analysis for XMAD:BST

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.23

Price

€0.30

GF Value

View XMAD:BST Analysis

See Dividends per Share data for all stocks →